Composition for lowering serum uric acid level
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- OTSUKA PHARM CO LTD
- Publication Date
- 2006-08-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The present invention relates to novel lactic acid bacteria and yeast strains having the effect of decomposing purines and lowering serum uric acid levels, and to compositions containing them (in the form of food, drink and medicine). Background of the invention
[0002] Hyperuricemia is a clinical syndrome manifested as a chronic abnormal state in which the blood uric acid level is pathologically higher and exceeds the normal range. In addition to severe painful gout caused by inflammation caused by crystal uric acid, patients with hyperuricemia are likely to develop kidney disease, urinary stones, cardiovascular disorders, and cerebrovascular disorders. In addition, hyperuricemia is considered a risk factor for arteriosclerosis.
[0003] Hyperuricemia is considered to be caused by an increase in uric acid produced in the body and a decrease in urinary excretion of uric acid by the kidneys and gallbladder. Uric acid is a metabolic waste product of p...